Cargando…
Diagnostic value of KLK6 as an ovarian cancer biomarker: A meta-analysis
Kallikrein-related peptidase 6 (KLK6) is a new potential serum biomarker of ovarian cancer. The aim of the present study was to assess the diagnostic value of KLK6 systematically for ovarian cancer. All the selected studies regarding the changes of KLK6 in ovarian cancer were published prior to Apri...
Autores principales: | YANG, FAN, HU, ZHI-DE, CHEN, YINGJIAN, HU, CHENG-JIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887959/ https://www.ncbi.nlm.nih.gov/pubmed/27284406 http://dx.doi.org/10.3892/br.2016.662 |
Ejemplares similares
-
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
por: Tamir, Ayala, et al.
Publicado: (2014) -
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma
por: White, N M A, et al.
Publicado: (2009) -
Correlation between KLK6 expression and the clinicopathological features of glioma
por: Lou, Jiangtao, et al.
Publicado: (2014) -
Analysis of expression and prognosis of KLK7 in ovarian cancer
por: Chen, Erhua, et al.
Publicado: (2020) -
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)